Press release
Gastric Cancer Market Size And Global Industry Forecast 2034
Gastric Cancer Market
Introduction
The Gastric Cancer Market focuses on one of the most prevalent and deadly malignancies worldwide, particularly in East Asia, Eastern Europe, and parts of South America. Gastric cancer, also known as stomach cancer, is often diagnosed in advanced stages due to non-specific early symptoms, making it a significant public health challenge.
Over the past decade, advancements in molecular diagnostics, targeted therapies, immunotherapy, and minimally invasive surgery have improved survival rates, especially for patients with HER2-positive or PD-L1-positive tumors. The next decade will see accelerated growth driven by precision oncology, liquid biopsy adoption, and integration of AI-based diagnostic tools into gastric cancer care.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70854
Market Overview
• Market Size 2024: USD 5.9 billion
• Forecast 2034: USD 10.2 billion
• CAGR (2024-2034): 5.6%
Key Highlights:
• Growing adoption of trastuzumab and immunotherapies for advanced gastric cancer.
• Rising use of laparoscopic and robotic-assisted gastrectomy for early-stage disease.
• Expanding application of next-generation sequencing (NGS) for biomarker-driven treatment.
• Asia-Pacific accounts for the highest incidence and fastest market growth.
Market Drivers:
• High prevalence in countries like Japan, China, and South Korea.
• Increasing government investment in cancer screening and prevention programs.
• Strong pipeline of targeted therapies and immuno-oncology drugs.
Market Challenges:
• Late-stage diagnosis in the majority of patients.
• Limited access to advanced treatments in low-income regions.
• Resistance development to targeted and immunotherapies.
Leading Players:
• Roche Holding AG
• Bristol Myers Squibb (BMS)
• AstraZeneca plc
• Merck & Co., Inc.
• Novartis AG
• Eli Lilly and Company
• Pfizer Inc.
• Amgen Inc.
• Zymeworks Inc.
• BeiGene, Ltd.
Segmentation Analysis
By Product
• Chemotherapy Agents
• Targeted Therapy (HER2 Inhibitors, VEGF Inhibitors, CLDN18.2 Inhibitors)
• Immunotherapy (PD-1/PD-L1 Inhibitors, CTLA-4 Inhibitors)
• Diagnostic Kits & Reagents
• Surgical Devices
By Platform
• Pharmaceuticals
• Diagnostics
• Medical Devices
By Technology
• Endoscopic Screening
• Next-Generation Sequencing (NGS)
• Immunohistochemistry (IHC)
• Liquid Biopsy
• Robotic-Assisted Surgery
By End Use
• Hospitals
• Specialty Oncology Clinics
• Diagnostic Laboratories
• Ambulatory Surgical Centers
By Application
• Early-Stage Gastric Cancer
• Advanced/Metastatic Gastric Cancer
Segmentation Summary:
Pharmaceuticals dominate due to strong demand for chemotherapy, targeted agents, and immunotherapies. Diagnostics are gaining market share as screening programs expand, particularly in high-risk regions.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70854
Regional Analysis
North America
• Moderate prevalence but high adoption of targeted and immunotherapies.
• U.S. leads in clinical trial activity for novel gastric cancer treatments.
Europe
• Strong adoption of biomarker testing and personalized therapy.
• Germany, France, and the UK lead in treatment innovation.
Asia-Pacific
• Largest and fastest-growing market due to high disease incidence, advanced screening programs, and strong adoption of novel therapies.
• Japan and South Korea have long-standing national screening programs for early detection.
Middle East & Africa
• Low awareness and limited access to advanced treatments.
• Gradual improvements in oncology care in major urban centers.
Latin America
• Brazil, Mexico, and Argentina driving regional growth with expanding oncology infrastructure.
• Partnerships with global pharma companies increasing treatment availability.
Regional Trends Summary:
Asia-Pacific is the largest market and growth leader, while North America and Europe remain at the forefront of drug innovation and clinical trials.
Market Dynamics
Key Growth Drivers
• High incidence in Asia-Pacific driving strong demand for screening and treatment.
• Biomarker-driven therapy adoption improving survival rates.
• Technological innovations in endoscopy and surgical robotics.
Key Challenges
• Late diagnosis limiting treatment effectiveness.
• Resistance to HER2 and PD-1/PD-L1 inhibitors.
• Healthcare disparities affecting access to novel therapies.
Latest Trends
• Expansion of CLDN18.2-targeted therapies in clinical trials.
• Use of AI in endoscopy for early detection of gastric lesions.
• Increasing application of liquid biopsy for minimal residual disease monitoring.
• Growing real-world evidence studies to optimize treatment sequencing.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70854/gastric-cancer-market
Competitor Analysis
Major Players:
1. Roche Holding AG - Herceptin, Tecentriq
2. Bristol Myers Squibb - Opdivo
3. AstraZeneca plc - Imfinzi, Enhertu (collaboration)
4. Merck & Co., Inc. - Keytruda
5. Novartis AG - Targeted oncology pipeline
6. Eli Lilly and Company - Cyramza
7. Pfizer Inc. - Targeted gastric cancer research
8. Amgen Inc. - Oncology pipeline
9. Zymeworks Inc. - Bispecific antibody development
10. BeiGene, Ltd. - PD-1 inhibitors
Competitive Summary:
The market is competitive, with Roche, Merck, and BMS leading in approved therapies, while Asian companies like BeiGene are gaining prominence in immuno-oncology. Partnerships between Western and Asian firms are key to expanding access in high-incidence regions.
Conclusion
The Gastric Cancer Market is projected to grow from USD 5.9 billion in 2024 to USD 10.2 billion by 2034, at a CAGR of 5.6%. The future of gastric cancer care lies in early detection, biomarker-driven precision therapy, and integration of AI and liquid biopsy technologies.
This report is also available in the following languages : Japanese (胃がん市場), Korean (위암 시장), Chinese (胃癌市场), French (Marché du cancer gastrique), German (Markt für Magenkrebs), and Italian (Mercato del cancro gastrico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70854
Our More Report:
Chlorella Supplements
https://exactitudeconsultancy.com/reports/65947/chlorella-supplements-market
Pediatric MRI Systems
https://exactitudeconsultancy.com/reports/65949/pediatric-mri-systems-market
Collagen Jelly
https://exactitudeconsultancy.com/reports/65945/collagen-jelly-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market Size And Global Industry Forecast 2034 here
News-ID: 4143904 • Views: …
More Releases from Exactitiude Consultancy
Malignant Ascites Market Key Players, Share and Forecast Outlook
Introduction
The Malignant Ascites market-focused on the accumulation of fluid in the peritoneal cavity due to advanced cancers-is witnessing growing clinical attention. While most cases are linked to ovarian, gastrointestinal, pancreatic, and liver cancers, improvements in palliative care and targeted oncology therapies are extending survival, thereby increasing the patient pool. Historically managed with repeated paracentesis, the treatment landscape is shifting toward indwelling catheter systems, intraperitoneal chemotherapy, and molecularly targeted drugs. Rising…
Leptomeningeal Metastases Market Size, Share and Growth Report, 2034
Introduction
The Leptomeningeal Metastases (LM) market is gaining increased attention as survival rates for primary cancers improve, leading to higher detection of late-stage complications like LM. This rare but severe condition occurs when cancer cells spread to the leptomeninges and cerebrospinal fluid (CSF), most often from breast cancer, lung cancer, or melanoma. Historically associated with poor prognosis, LM treatment is evolving with advancements in molecular diagnostics, targeted therapies, intrathecal drug delivery…
Head and Neck Cancer Market Size And Global Industry Forecast 2034
Introduction
The global head and neck cancer market is undergoing a transformative phase, driven by advances in oncology research, the growing burden of cancer cases, and expanding access to novel therapies. Head and neck cancers - a group of biologically similar cancers that start in the lip, oral cavity, nasal cavity, pharynx, larynx, salivary glands, and other related structures - represent a significant health challenge worldwide. Increasing tobacco and alcohol consumption,…
GM1 Gangliosidosis Market Industry Analysis by Size, Share, Growth, Sourcing Str …
GM1 Gangliosidosis Market Size, Share, Trends, and Forecast 2024-2034
Introduction
GM1 gangliosidosis is a rare, inherited lysosomal storage disorder caused by mutations in the GLB1 gene, leading to a deficiency in the enzyme beta-galactosidase. This enzyme deficiency causes the accumulation of GM1 gangliosides in the brain and other tissues, resulting in progressive neurological deterioration and multi-systemic complications. The condition is classified into Type I (infantile), Type II (late-infantile/juvenile), and Type III (adult/chronic)…
More Releases for Gastric
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not.
The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller…
